Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Europlasma to display nanocoating systems for electronic devices at CES 2014

Belgium based Europlasma, a world leader in low pressure plasma technology, is happy to present at CES 2014 its nanocoating systems for the electronics industry under the Nanofics® brand name.

7 Jan 2014

Cancer cells less likely to develop resistance when multiple drugs delivered simultaneously

Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.

7 Jan 2014

BioLife Solutions announces preliminary revenue of $9 million for 2013

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.

6 Jan 2014

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases.

6 Jan 2014

Neogen acquires the stock of Chem-Tech

Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.

2 Jan 2014

Marrone Bio Innovations commences production of Grandevo bioinsecticide at Michigan plant

Marrone Bio Innovations, Inc. (MBI), a leading global provider of bio-based pest management and plant health products announced it has initiated production of Grandevo®, the company's flagship bioinsecticide, at its Bangor, MI plant. This is the company's first production of a fermentation product at this location since renovation of the plant, acquired in July 2012, was initiated.

27 Dec 2013

Teva Pharmaceuticals sells 31 generic drug products to ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.

27 Dec 2013

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

Nearly 3.3 billion people, a little less than half of our world’s population, are at risk of malaria, TB and what we call “neglected tropical diseases”—diseases caused by worms, parasites, viruses and bacteria like Chagas disease, river blindness, elephantiasis, sleeping sickness, etc.

24 Dec 2013

Rutgers New Jersey Medical School's David Perlin explains how fungal infections can become deadly

Ask someone what the term 'fungus' brings to mind, and chances are it will be an image of something that smells or looks disgusting. Ask David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, and the response will be far more somber - because he knows how deadly fungi can be.

24 Dec 2013

Polymer Technology acquires A1CNow family of products from Bayer Diabetes Care

Polymer Technology Systems, Inc., the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, announced today that it has acquired the A1CNow® family of products from Bayer Diabetes Care.

23 Dec 2013

Engineered immune cells show antitumor activity in two patients with advanced cancers

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatments, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.

22 Dec 2013

New research assesses nanomedicine-based approaches for treating cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.

20 Dec 2013

Bristol-Myers Squibb signs agreement to sell global diabetes business

Bristol-Myers Squibb Company today announced that it has signed an agreement to sell its global diabetes business that was part of its collaboration with AstraZeneca. Under terms of the agreement, AstraZeneca will make an upfront payment of $2.7 billion to Bristol-Myers Squibb, with potential regulatory- and sales-based milestone payments of up to $1.4 billion and will make royalty payments based on net sales through 2025.

19 Dec 2013

KIT researchers develop novel gel for biological and medical applications

A novel method developed by researchers from Karlsruhe Institute of Technology (KIT) and Jacobs University Bremen enables manufacturing of polymer layers with tailor-made properties and multiple functions: A stable porous gel (SURGEL) for biological and medical applications is obtained from a metal-organic framework (SURMOF) grown up on a substrate.

19 Dec 2013

TGen, Nemucore, and Barrow collaboration aims for new drugs to treat glioblastoma

The Ben & Catherine Ivy Foundation today announced a $3 million grant to the Translational Genomics Research Institute (TGen), Nemucore Medical Innovations Inc., and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center to help fund significant brain tumor research in Arizona.

18 Dec 2013

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

The National Institutes of Health today has launched three pre-clinical projects to advance potential new treatments for acute radiation syndrome, brain injury following cardiac arrest and a rare blood disorder called beta thalassemia.

17 Dec 2013

SynCardia Systems raises $14M to fund the rapid growth of Total Artificial Heart

Privately held SynCardia Systems, Inc. announced today that it had raised $14 million to fund the rapid growth of the only approved medical device that eliminates the symptoms and source of end-stage heart failure, the SynCardia temporary Total Artificial Heart. The SynCardia Total Artificial Heart is the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.

17 Dec 2013

Probiotics could be next potential weapon to fight malnutrition

The University of British Columbia public affairs office has published today a story on probiotic intervention as the next potential weapon against malnutrition.

17 Dec 2013

Biogen joins with Samsung Bioepis to commercialize anti-TNF biosimilar product candidates in Europe

Biogen Idec (NASDAQ: BIIB) and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to commercialize anti-TNF biosimilar product candidates in Europe, including biosimilars for widely used therapies to treat conditions such as rheumatoid arthritis and Crohn's disease.

17 Dec 2013

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Stem cells have a potential to develop into multiple cell types and divide without limit to replenish cells in human body throughout the life of individual.

16 Dec 2013

Manufacturing News and Research

Further Reading

Europlasma to display nanocoating systems for electronic devices at CES 2014

Cancer cells less likely to develop resistance when multiple drugs delivered simultaneously

BioLife Solutions announces preliminary revenue of $9 million for 2013

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Neogen acquires the stock of Chem-Tech

Marrone Bio Innovations commences production of Grandevo bioinsecticide at Michigan plant

Teva Pharmaceuticals sells 31 generic drug products to ANI Pharmaceuticals

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

Rutgers New Jersey Medical School's David Perlin explains how fungal infections can become deadly

Polymer Technology acquires A1CNow family of products from Bayer Diabetes Care

Engineered immune cells show antitumor activity in two patients with advanced cancers

New research assesses nanomedicine-based approaches for treating cancer

Bristol-Myers Squibb signs agreement to sell global diabetes business

KIT researchers develop novel gel for biological and medical applications

TGen, Nemucore, and Barrow collaboration aims for new drugs to treat glioblastoma

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

SynCardia Systems raises $14M to fund the rapid growth of Total Artificial Heart

Probiotics could be next potential weapon to fight malnutrition

Biogen joins with Samsung Bioepis to commercialize anti-TNF biosimilar product candidates in Europe

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®